# IOVA (Iovance Biotherapeutics, Inc.) - SEC EDGAR Financial Statements

> Iovance Biotherapeutics, Inc. reported $379.0M in revenue and a net loss of $220.5M for the trailing twelve months ended September 30, 2026 (up 80.1% year over year), with a 53.2% gross margin and a -60.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/IOVA
- Markdown: https://convexityos.com/fundamentals/IOVA.md
- SEC CIK: 0001425205
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001425205&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $379.0M | +80.1% YoY |
| Operating Income | TTM | -$230.4M | -60.8% margin |
| Net Income | TTM | -$220.5M | -58.2% net margin |
| Diluted EPS | TTM | -$0.48 | Split-adjusted |
| Free Cash Flow | TTM | -$216.1M | -57.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $376.3M | Total debt: $45.21M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $263.5M | $164.1M | $1.19M | -- | -- | -- | -- | $0 | $0 | $0 |
| Cost of Revenue | $173.2M | $93.25M | $1.03M | -- | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $90.32M | $70.82M | $156K | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $300.3M | $276.2M | $333.2M | $294.8M | $259.0M | $201.7M | $166.0M | $99.83M | $71.61M | $26.94M |
| Total Operating Expenses | -- | -- | -- | $398.9M | $342.7M | $261.9M | $206.9M | $128.3M | $92.88M | $53.64M |
| **Operating Income** | -$403.4M | -$395.3M | -$460.6M | -$398.9M | -$342.7M | -$261.9M | -$206.9M | -$128.3M | -$92.88M | -$53.64M |
| **EBITDA** | -$390.5M | -$384.0M | -$449.0M | -$389.6M | -$339.6M | -$260.8M | -$205.7M | -$127.3M | -$91.92M | -$52.66M |
| Interest Income | $10.31M | $20.27M | $13.04M | $2.98M | $451K | $2.36M | $9.32M | $4.68M | $813K | $745K |
| Income Before Tax | -$393.0M | -$375.0M | -$447.5M | -$395.9M | -$342.3M | -- | -- | -- | -- | -- |
| Income Tax Expense | -$2.07M | -$2.83M | -$3.48M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$391.0M | -$372.2M | -$444.0M | -$395.9M | -$342.3M | -$259.6M | -$197.6M | -$123.6M | -$92.06M | -$52.89M |
| Basic EPS | -$1.09 | -$1.28 | -$1.89 | -$2.49 | -$2.23 | -$1.88 | -$1.59 | -$1.27 | -$1.41 | -$1.85 |
| **Diluted EPS** | -$1.09 | -$1.28 | -$1.89 | -$2.49 | -$2.23 | -$1.88 | -$1.59 | -$1.27 | -$1.41 | -$1.85 |
| Basic Shares Outstanding | 357.3K | 289.9K | 235.1K | 159.3K | 153.4K | 138.3K | 124.3K | 97.3K | 65.2K | 55.3K |
| Diluted Shares Outstanding | 357.3K | 289.9K | 235.1K | 159.3K | 153.4K | 138.3K | 124.3K | 97.3K | 65.2K | 55.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $121.5M | $99.31M | $71.43M | $86.77M | $67.45M | $59.95M | $49.32M | $73.69M |
| Cost of Revenue | $48.03M | $43.59M | $42.50M | $43.11M | $38.48M | $48.88M | $42.72M | $37.79M |
| **Gross Profit** | $73.44M | $55.72M | $28.93M | $43.66M | $28.98M | $11.07M | $6.61M | $35.91M |
| Research & Development | $49.34M | $58.85M | $62.49M | $71.20M | $75.17M | $77.93M | $75.97M | $71.01M |
| **Operating Income** | -$23.97M | -$51.91M | -$81.04M | -$73.46M | -$94.90M | -$113.8M | -$121.2M | -$86.58M |
| **EBITDA** | -$20.17M | -$48.12M | -$78.22M | -$69.74M | -$91.71M | -$110.4M | -$118.7M | -$83.30M |
| Interest Income | $2.31M | $3.22M | $1.33M | $1.74M | $1.24M | $4.10M | $3.22M | $9.57M |
| Income Before Tax | -$21.66M | -$48.69M | -$79.71M | -$71.72M | -$93.66M | -$109.7M | -$118.0M | -$77.00M |
| Income Tax Expense | $614K | -$1.37M | -$665K | $184K | -$2.40M | $1.99M | -$1.84M | $1.56M |
| **Net Income** | -$22.27M | -$47.31M | -$79.05M | -$71.90M | -$91.25M | -$111.7M | -$116.2M | -$78.56M |
| Basic EPS | -$0.05 | -$0.11 | -$0.19 | -- | -$0.25 | -$0.33 | -$0.36 | -- |
| **Diluted EPS** | -$0.05 | -$0.11 | -$0.19 | -- | -$0.25 | -$0.33 | -$0.36 | -- |
| Basic Shares Outstanding | 455.9M | 450.2K | 418.5K | -- | 364.0M | 334.5K | 322.9K | -- |
| Diluted Shares Outstanding | 455.9M | 450.2K | 418.5K | -- | 364.0M | 334.5K | 322.9K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $163.1M | $115.7M | $114.9M | $231.7M | $78.23M | $67.33M | $13.97M | $82.15M | $145.4M | $106.7M |
| Short-Term Investments | $133.9M | $208.1M | $165.0M | $240.1M | $426.2M | $562.1M | $293.1M | $386.4M | -- | -- |
| **Cash & Short-Term Investments** | $297.0M | $323.8M | $279.9M | $471.8M | $504.4M | $635.0M | $307.1M | $386.4M | $0 | $166.5M |
| Accounts Receivable, Net | $82.45M | $69.34M | $151K | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $51.68M | $51.52M | $10.37M | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $442.7M | $457.0M | $307.8M | $479.1M | $508.0M | $636.1M | $316.5M | $475.4M | $149.3M | $169.5M |
| Property, Plant & Equipment, Net | $131.1M | $109.1M | $114.0M | $105.2M | $100.9M | $59.16M | $8.54M | $2.68M | $2.45M | $2.37M |
| Intangible Assets | $279.3M | $282.4M | $229.3M | -- | -- | -- | -- | -- | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | $91.59M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $8.17M | $369K | $270K | $189K | $1.78M | $12.92M | $3.48M | $2.76M | $3.63M | $0 |
| **Total Non-Current Assets** | $470.5M | $453.4M | $472.5M | $184.9M | $269.4M | $132.4M | $28.16M | $5.45M | $6.08M | $2.37M |
| **Total Assets** | $913.2M | $910.4M | $780.4M | $664.0M | $777.3M | $768.5M | $344.7M | $480.8M | $155.4M | $171.9M |
| Accounts Payable | $22.16M | $27.51M | $33.12M | $26.60M | $27.38M | $13.51M | $15.57M | $2.74M | $1.23M | $863K |
| **Total Current Liabilities** | $138.4M | $122.3M | $110.3M | $91.48M | $89.20M | $54.87M | $39.08M | $14.40M | $9.60M | $4.97M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $11.71M | $2.35M | $230K | -- | -- |
| **Total Non-Current Liabilities** | $76.23M | $77.68M | $85.43M | $72.86M | $66.47M | $57.09M | $6.60M | $230K | $297K | $0 |
| **Total Liabilities** | $214.6M | $200.0M | $195.7M | $164.3M | $155.7M | $112.0M | $45.68M | $14.63M | $9.89M | $4.97M |
| **Total Debt (incl. Leases)** | $48.44M | $57.26M | $74.86M | $84.45M | $70.53M | $51.66M | $11.50M | -- | -- | -- |
| Common Stock | $17K | $13K | $11K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K |
| Retained Earnings | -$2.78B | -$2.38B | -$2.01B | -$1.57B | -$1.17B | -$830.2M | -$570.6M | -$372.8M | -$249.2M | -$157.1M |
| Accumulated Other Comp. Income | $16.44M | -$1.05M | $2.53M | -$902K | -$601K | $19K | $220K | -$42K | $0 | $29K |
| **Total Stockholders' Equity** | $698.6M | $710.4M | $584.6M | $499.6M | $621.7M | $656.5M | $299.0M | $466.2M | $145.5M | $166.9M |
| Total Equity | $698.6M | $710.4M | $584.6M | $499.6M | $621.7M | $656.5M | $299.0M | $466.2M | $145.5M | $166.9M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $57.93M | $110.8M | $196.5M | $163.1M | $158.1M | $132.5M | $171.7M | $115.7M |
| Short-Term Investments | $318.4M | $186.9M | $116.9M | $133.9M | $142.7M | $168.7M | $188.0M | $208.1M |
| **Cash & Short-Term Investments** | $376.3M | $297.7M | $313.4M | $297.0M | $300.8M | $301.2M | $359.7M | $323.8M |
| Accounts Receivable, Net | $107.0M | $102.1M | $81.76M | $82.45M | $66.76M | $59.94M | $70.94M | $69.34M |
| Inventory | $55.22M | $55.59M | $58.38M | $51.68M | $51.71M | $49.83M | $65.55M | $51.52M |
| **Total Current Assets** | $549.6M | $464.3M | $466.5M | $442.7M | $429.1M | $422.5M | $512.6M | $457.0M |
| Property, Plant & Equipment, Net | $129.3M | $131.5M | $131.4M | $131.1M | $126.7M | $122.5M | $111.6M | $109.1M |
| Intangible Assets | $259.2M | $263.9M | $269.1M | $279.3M | $285.2M | $296.3M | $285.4M | $282.4M |
| Other Non-Current Assets | $4.48M | $6.43M | $8.29M | $8.17M | $9.27M | $10.32M | $426K | $369K |
| **Total Non-Current Assets** | $441.6M | $451.3M | $459.2M | $470.5M | $475.9M | $484.9M | $454.1M | $453.4M |
| **Total Assets** | $991.2M | $915.5M | $925.7M | $913.2M | $904.9M | $907.4M | $966.7M | $910.4M |
| Accounts Payable | $21.64M | $26.21M | $37.45M | $22.16M | $31.24M | $32.00M | $28.49M | $27.51M |
| **Total Current Liabilities** | $105.8M | $106.8M | $129.4M | $138.4M | $125.8M | $129.2M | $122.7M | $122.3M |
| **Total Non-Current Liabilities** | $72.78M | $72.64M | $74.49M | $76.23M | $76.88M | $79.79M | $76.18M | $77.68M |
| **Total Liabilities** | $178.6M | $179.5M | $203.9M | $214.6M | $202.7M | $208.9M | $198.9M | $200.0M |
| **Total Debt (incl. Leases)** | $45.21M | $46.00M | $46.78M | $48.44M | $51.49M | $52.17M | $52.72M | $57.26M |
| Common Stock | $19K | $19K | $18K | $17K | $16K | $14K | $14K | $13K |
| Retained Earnings | -$2.92B | -$2.90B | -$2.85B | -$2.78B | -$2.70B | -$2.61B | -$2.50B | -$2.38B |
| Accumulated Other Comp. Income | $13.85M | $13.08M | $12.65M | $16.44M | $16.10M | $20.86M | $6.29M | -$1.05M |
| **Total Stockholders' Equity** | $812.7M | $736.0M | $721.8M | $698.6M | $702.3M | $698.5M | $767.9M | $710.4M |
| Total Equity | $812.7M | $736.0M | $721.8M | $698.6M | $702.3M | $698.5M | $767.9M | $710.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$391.0M | -$372.2M | -$444.0M | -$395.9M | -$342.3M | -$259.6M | -$197.6M | -$123.6M | -$92.06M | -$52.89M |
| Depreciation & Amortization | $12.86M | $11.26M | $11.57M | $9.31M | $3.11M | $1.14M | $1.17M | $956K | $952K | $978K |
| Stock-Based Compensation | $61.58M | $109.6M | $62.62M | $84.02M | $69.77M | $40.89M | $24.28M | $20.03M | $11.97M | $18.90M |
| Change in Receivables | -$13.11M | -$69.19M | -$149K | -- | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$14.21M | -$44.38M | -$10.12M | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$6.66M | -$7.84M | $4.83M | $5.88M | $6.98M | -$2.96M | $12.71M | $1.51M | $369K | -$250K |
| **Operating Cash Flow** | -$302.4M | -$353.0M | -$361.8M | -$292.8M | -$227.9M | -$205.1M | -$158.9M | -$101.2M | -$78.71M | -$32.67M |
| Capital Expenditure | -$33.84M | -$11.07M | -$22.29M | -$20.43M | -$37.57M | -$46.79M | -$6.92M | -$1.20M | -$1.03M | -$1.52M |
| **Free Cash Flow** | -$336.2M | -$364.0M | -$384.1M | -$313.2M | -$265.5M | -$251.9M | -$165.8M | -$102.4M | -$79.74M | -$34.19M |
| Acquisitions, Net | -- | -- | -$212.6M | -- | -- | -- | -- | -- | -- | -- |
| Purchases of Investments | -$318.7M | -$460.8M | -$205.9M | -$245.8M | -$725.2M | -$947.7M | -$417.7M | -$426.1M | -- | -- |
| **Investing Cash Flow** | $47.50M | -$96.41M | -$155.2M | $256.5M | $132K | -$317.9M | $90.03M | -$386.3M | $58.68M | $8.89M |
| Common Stock Issued | $306.3M | $397.3M | $463.3M | $189.5M | $203.2M | $567.0M | -- | $398.8M | $53.66M | $95.69M |
| **Financing Cash Flow** | $300.8M | $390.7M | $463.0M | $190.2M | $239.3M | $576.4M | $6.13M | $424.3M | $58.69M | $96.90M |
| **Net Change in Cash** | $47.01M | -$59.27M | -$56.84M | $153.8M | $11.46M | $53.44M | -$62.73M | -$63.22M | $38.66M | $73.13M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$22.27M | -$47.31M | -$79.05M | -$71.90M | -$91.25M | -$111.7M | -$116.2M | -$78.56M |
| Depreciation & Amortization | $3.80M | $3.78M | $2.82M | $3.72M | $3.19M | $3.40M | $2.57M | $3.27M |
| Stock-Based Compensation | $11.83M | $11.73M | $11.27M | $11.82M | $11.90M | $14.94M | $22.91M | $30.98M |
| Change in Receivables | -$4.87M | -$20.36M | $690K | -$15.69M | -$6.82M | $11.00M | -$1.60M | -$13.57M |
| Change in Inventory | $596K | -$177K | -$4.93M | -$4.00M | -$3.02M | $6.65M | -$13.83M | -$18.93M |
| Change in Payables | -$2.60M | -$11.82M | $15.89M | -$5.21M | -$4.39M | $893K | $2.05M | -$6.07M |
| **Operating Cash Flow** | -$4.47M | -$60.84M | -$72.07M | -$52.56M | -$78.70M | -$67.45M | -$103.7M | -$73.30M |
| Capital Expenditure | -$4.74M | -$5.44M | -$6.61M | -$9.32M | -$10.84M | -$7.46M | -$6.21M | -$4.17M |
| **Free Cash Flow** | -$9.21M | -$66.28M | -$78.68M | -$61.88M | -$89.55M | -$74.91M | -$109.9M | -$77.46M |
| Purchases of Investments | -$186.8M | -$129.6M | -$56.00M | -$59.91M | -$92.14M | -$68.70M | -$97.92M | -$88.16M |
| **Investing Cash Flow** | -$134.6M | -$74.05M | $11.39M | $775K | $17.01M | $13.84M | $15.87M | $23.68M |
| Common Stock Issued | $87.90M | $49.57M | $98.51M | $55.78M | $88.52M | $13.06M | $148.9M | $0 |
| **Financing Cash Flow** | $86.28M | $49.29M | $94.33M | $56.17M | $88.06M | $13.23M | $143.3M | $2.31M |
| **Net Change in Cash** | -$52.82M | -$85.73M | $33.44M | $4.96M | $25.69M | -$39.64M | $56.00M | -$48.49M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 34.3% | 43.2% | 13.1% | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -153.1% | -240.9% | -38735.0% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -148.4% | -226.8% | -37345.4% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -56.0% | -52.4% | -76.0% | -79.2% | -55.1% | -39.5% | -66.1% | -26.5% | -63.3% | -31.7% |
| Return on Assets (ROA) | -42.8% | -40.9% | -56.9% | -59.6% | -44.0% | -33.8% | -57.3% | -25.7% | -59.3% | -30.8% |
| Current Ratio | 3.20x | 3.74x | 2.79x | 5.24x | 5.69x | 11.59x | 8.10x | 33.02x | 15.56x | 34.12x |
| Quick Ratio | 2.83x | 3.31x | 2.70x | 5.16x | 5.65x | 11.57x | 7.86x | 26.84x | 0.00x | 33.51x |
| Debt to Equity | 0.07x | 0.08x | 0.13x | 0.17x | 0.11x | 0.08x | 0.04x | -- | -- | -- |
| **Revenue Growth (YoY)** | +60.6% | +13699.0% | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +27.5% | +45298.7% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 53.2% | 48.4% | 39.4% | 34.3% | 33.0% | 33.4% | 32.6% | 34.2% |
| **Operating Margin** | -60.8% | -92.7% | -127.2% | -153.1% | -166.3% | -170.0% | -187.5% | -240.9% |
| **Net Profit Margin** | -58.2% | -89.1% | -123.9% | -148.4% | -158.8% | -161.4% | -176.5% | -226.8% |
| Return on Equity (ROE) | -27.1% | -39.3% | -49.0% | -56.0% | -56.6% | -55.8% | -48.9% | -52.4% |
| Return on Assets (ROA) | -22.2% | -31.6% | -38.2% | -42.8% | -43.9% | -43.0% | -38.8% | -40.9% |
| Current Ratio | 5.20x | 4.35x | 3.60x | 3.20x | 3.41x | 3.27x | 4.18x | 3.74x |
| Quick Ratio | 4.67x | 3.82x | 3.15x | 2.83x | 3.00x | 2.89x | 3.64x | 3.31x |
| Debt to Equity | 0.06x | 0.06x | 0.06x | 0.07x | 0.07x | 0.07x | 0.07x | 0.08x |
| **Revenue Growth (YoY)** | +80.1% | +65.7% | +44.8% | +17.7% | +15.2% | +92.7% | +6798.5% | -- |
| Gross Profit Growth (YoY) | +153.4% | +403.3% | +337.8% | +21.6% | +7.2% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
